Uganda now faces a complex epidemiological situation with the confirmed detection of its first Marburg virus case in 2026, occurring simultaneously with an ongoing Ebola outbreak. Three critical points merit attention: first, this represents Uganda’s inaugural confirmed Marburg diagnosis in 2026; second, the case was identified through rigorous differential diagnostic testing rather than initial clinical presentation; and third, WHO response teams are already positioned on the ground to support containment efforts. The 18-month-old patient from Kyegegwa district initially presented as a suspected Ebola case, underscoring the clinical overlap between viral haemorrhagic fevers.
Dual outbreak management presents significant operational and epidemiological challenges for health authorities. Resources, laboratory capacity, and personnel must now address two distinct pathogens requiring different containment strategies. Healthcare providers should maintain heightened clinical awareness, ensuring comprehensive testing protocols for all suspected viral haemorrhagic fever cases. Clinicians should expect evolving guidance from WHO and national health authorities as surveillance continues. Close monitoring for additional cases and strict infection prevention measures will remain paramount.
Read the full article on GMJ Newsroom.
Was this article helpful?
